Dudhe SB, Ghule S. Lipid-Based Formulation of Nateglinide as a Promising Strategy for Managing Solubility Challenges in Type II Diabetes Therapy: A SMEDDS Approach. J Neonatal Surg [Internet]. 2025 Jun. 16 [cited 2026 Apr. 15];14(32S):369-77. Available from: https://jneonatalsurg.com/index.php/jns/article/view/7379